These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 1858387)
1. Clinical syndromes with vasoconstrictor response. Gasser P Wien Klin Wochenschr; 1991; 103(8):217-21. PubMed ID: 1858387 [TBL] [Abstract][Full Text] [Related]
2. [Raynaud's syndrome: diagnosis and therapy in general practice]. Gasser P Schweiz Rundsch Med Prax; 1989 Aug; 78(33):868-73. PubMed ID: 2678363 [TBL] [Abstract][Full Text] [Related]
8. Lack of habituation of the pattern of cardiovascular response evoked by sound in subjects with primary Raynaud's disease. Edwards CM; Marshall JM; Pugh M Clin Sci (Lond); 1998 Sep; 95(3):249-60. PubMed ID: 9730843 [TBL] [Abstract][Full Text] [Related]
10. Raynaud's phenomenon and systemic sclerosis. Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438 [TBL] [Abstract][Full Text] [Related]
11. Prompt termination and/or prevention of cold-pressor-stimulus-induced vasoconstriction of different vascular beds by magnesium sulfate in patients with Prinzmetal's angina. Cohen L; Kitzes R Magnesium; 1986; 5(3-4):144-9. PubMed ID: 3724238 [TBL] [Abstract][Full Text] [Related]
12. Psychophysical mechanisms and treatment of vasospastic disorders in normal-tension glaucoma. Flammer J Bull Soc Belge Ophtalmol; 1992; 244():129-34. PubMed ID: 1297507 [TBL] [Abstract][Full Text] [Related]
13. Coronary vasospasm: a case report and review of the literature. Van Spall HG; Overgaard CB; Abramson BL Can J Cardiol; 2005 Sep; 21(11):953-7. PubMed ID: 16239980 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of Raynaud's phenomenon. Herrick AL Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of humeral blood flow during rewarming and recooling of the hand in normal subjects or presenting Raynaud's phenomenon]. Savin E; Kedra AW; Oliva I; Bonnin P; Martineaud JP J Mal Vasc; 1989; 14(4):312-9. PubMed ID: 2685159 [TBL] [Abstract][Full Text] [Related]
16. [Secondary Raynaud's syndrome: skin blood flow decrease between the ischemic episodes and prolongation of the vasoconstriction during the respiratory maneuvers]. Ortiz-Nieva G; Estañol B; Téllez-Zenteno JF; García-Villa M; Corona-Marco V; Padilla-Rubio J; Cardiel-Ríos MH; García-Ramos G Arch Cardiol Mex; 2004; 74(3):181-91. PubMed ID: 15559870 [TBL] [Abstract][Full Text] [Related]
17. The role of botulinum toxin in vasospastic disorders of the hand. Neumeister MW Hand Clin; 2015 Feb; 31(1):23-37. PubMed ID: 25455354 [TBL] [Abstract][Full Text] [Related]
18. Inflammation in variant angina: is there any evidence? Li JJ; Nie SP; Xu B; Guo YL; Gao Z; Zheng X Med Hypotheses; 2007; 68(3):635-40. PubMed ID: 17030449 [TBL] [Abstract][Full Text] [Related]
19. Raynaud's phenomenon: pathogenesis and management. Bakst R; Merola JF; Franks AG; Sanchez M J Am Acad Dermatol; 2008 Oct; 59(4):633-53. PubMed ID: 18656283 [TBL] [Abstract][Full Text] [Related]
20. Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis. Sunderkötter C; Riemekasten G Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii33-5. PubMed ID: 16987831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]